Antibiotics 2014, 3(3), 375-377; doi:10.3390/antibiotics3030375
Editorial

Urinary Tract Infections

1 and 2,* email
Received: 16 July 2014; Accepted: 23 July 2014 / Published: 14 August 2014
(This article belongs to the Special Issue Antibiotics and Urinary Tract Infections)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Note: In lieu of an abstract, this is an excerpt from the first page.

Excerpt: Urinary tract infections (UTI) are among the most frequently acquired infections in the community, but also in hospitals and other health care institutions, causing a huge amount of antibiotic consumption. During the last decade we have seen significant changes in the field of urinary tract infections regarding causative pathogens and antibiotic treatment calling for an update of current trends. The worldwide increase of uropathogens resistant to former first line antibiotics, such as cotrimoxazole, fluoroquinolones and cephalosporins, has had detrimental consequences not only for treatment but also for prophylaxis of infectious complications after urological interventions. A paradigm shift concerning asymptomatic bacteriuria has had a great impact on the definition and management of UTIs today [1–4]. [...]
PDF Full-text Download PDF Full-Text [295 KB, uploaded 14 August 2014 08:38 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Johansen, T.E.B.; Naber, K.G. Urinary Tract Infections. Antibiotics 2014, 3, 375-377.

AMA Style

Johansen TEB, Naber KG. Urinary Tract Infections. Antibiotics. 2014; 3(3):375-377.

Chicago/Turabian Style

Johansen, Truls E.B.; Naber, Kurt G. 2014. "Urinary Tract Infections." Antibiotics 3, no. 3: 375-377.

Antibiotics EISSN 2079-6382 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert